Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)
Hong Kong · Delayed Price · Currency is HKD 0.1030
+0.0030 (3.00%)
Aug 27, 2026, 3:35 PM HKT
HKG:8217 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 23.32 | -5.9 | -17.43 | -9.96 | -20.15 |
Depreciation & Amortization | 0.04 | 0.08 | 0.08 | 0.11 | 0.34 |
Loss (Gain) From Sale of Assets | -2.8 | - | - | -0.56 | -0.09 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.51 |
Loss (Gain) From Sale of Investments | - | - | 13.29 | 1.39 | -1.99 |
Stock-Based Compensation | - | - | - | - | 2.57 |
Provision & Write-off of Bad Debts | -1.35 | 3.55 | -1.07 | 4 | 11.58 |
Other Operating Activities | -26.67 | -4.63 | 0.72 | 0.72 | -0.47 |
Change in Accounts Receivable | 18.18 | 1.02 | 8.15 | 32.11 | -0.77 |
Change in Accounts Payable | -2.91 | -1.39 | 0.62 | 5.38 | -8.67 |
Change in Unearned Revenue | -1.24 | - | - | -1.88 | 3.4 |
Change in Other Net Operating Assets | 1.24 | - | -0.7 | 1.88 | -3.4 |
Operating Cash Flow | 7.81 | -7.27 | 3.72 | 32.23 | -19.52 |
Operating Cash Flow Growth | - | - | -88.45% | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Sale of Property, Plant & Equipment | 2.92 | - | - | 0.8 | 0.09 |
Investment in Securities | 4.07 | - | - | - | - |
Other Investing Activities | - | - | - | 0.01 | - |
Investing Cash Flow | 7 | - | - | 0.81 | 0.09 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 5.38 | - | - | - |
Total Debt Issued | - | 5.38 | - | - | - |
Short-Term Debt Repaid | -7.64 | - | -7.77 | -32.93 | -41.01 |
Long-Term Debt Repaid | - | - | - | -0.16 | -0.27 |
Total Debt Repaid | -7.64 | - | -7.77 | -33.09 | -41.28 |
Net Debt Issued (Repaid) | -7.64 | 5.38 | -7.77 | -33.09 | -41.28 |
Issuance of Common Stock | - | - | - | - | 54.85 |
Other Financing Activities | - | - | -0.1 | - | -1.52 |
Financing Cash Flow | -7.64 | 5.38 | -7.87 | -33.09 | 12.05 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 7.16 | -1.89 | -4.15 | -0.05 | -7.37 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 7.81 | -7.27 | 3.72 | 32.23 | -19.52 |
Free Cash Flow Growth | - | - | -88.45% | - | - |
Free Cash Flow Margin | 20.80% | -20.08% | 10.59% | 30.81% | -21.04% |
Free Cash Flow Per Share | 0.03 | -0.02 | 0.01 | 0.11 | -0.10 |
Levered Free Cash Flow | 4.95 | 1.87 | 4.6 | 33.28 | 2.39 |
Unlevered Free Cash Flow | 5.4 | 2.32 | 5.05 | 33.73 | 2.85 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | 0.1 | - | - |
Change in Working Capital | 15.27 | -0.37 | 8.14 | 36.53 | -11.81 |